HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TMC6
transmembrane channel like 6
Chromosome 17 Β· 17q25.3
NCBI Gene: 11322Ensembl: ENSG00000141524.19HGNC: HGNC:18021UniProt: A0A8V8TLY1
45PubMed Papers
21Diseases
0Drugs
36Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingintracellular zinc ion homeostasisprotein stabilizationcytoplasmepidermodysplasia verruciformisgenetic disorderhypertensionresponse to xenobiotic stimulus
✦AI Summary

TMC6 is a transmembrane regulatory protein with multiple cellular functions. In keratynocytes and lymphocytes, TMC6 forms a complex with its homolog TMC8 and the protein CIB1, where TMC6 stabilizes CIB1 and reciprocally regulates its activity 12. Additionally, TMC6 and TMC8 together activate the zinc transporter ZNT1 at the endoplasmic reticulum membrane, facilitating zinc uptake into the ER and downregulating zinc-induced transcription factors 3. In primary sensory neurons, TMC6 modulates thermal sensation by inhibiting M-channel (KCNQ2-KCNQ3) activity; TMC6 deletion increases M-channel function through elevated intracellular zinc, reducing heat hyperalgesia in chr17 pain models 4. Clinically, biallelic TMC6 mutations cause epidermodysplasia verruciformis (EV), an autosomal recessive disorder predisposing to persistent human papillomavirus (HPV) infection and cutaneous squamous cell carcinoma, particularly in UV-exposed regions 56. The TMC6-TMC8-CIB1 complex appears critical for immune control of Ξ²HPV rather than direct viral restriction 6. TMC6 variants also associate with psoriasis susceptibility 7 and cervical cancer risk 8, and genome-wide studies link TMC6-TMC8 to glycated hemoglobin levels 9.

Sources cited
1
TMC6 forms complex with TMC8 and CIB1 in lymphocytes and keratynocytes where TMC6 stabilizes CIB1
PMID: 30068544
2
TMC6 and TMC8 stabilize CIB1 with reciprocal regulation
PMID: 32917726
3
TMC6 and TMC8 activate zinc transporter ZNT1 at ER membrane and downregulate zinc-induced transcription factors
PMID: 18158319
4
TMC6 in DRG neurons inhibits M-channel activity and modulates thermal sensation; TMC6 deletion increases M-channel function and reduces heat hyperalgesia
PMID: 38440182
5
TMC6 mutations cause epidermodysplasia verruciformis with susceptibility to HPV and cutaneous squamous cell carcinoma
PMID: 24643182
6
TMC6-TMC8-CIB1 complex is critical for cellular immune control of Ξ²HPV infection
PMID: 39813296
7
TMC6 variants associate with psoriasis susceptibility
PMID: 25854761
8
TMC6 variants associate with cervical cancer susceptibility
PMID: 21387292
9
TMC6-TMC8 locus associates with glycated hemoglobin levels in genome-wide meta-analysis
PMID: 29170429
Disease Associationsβ“˜21
epidermodysplasia verruciformisOpen Targets
0.76Strong
genetic disorderOpen Targets
0.19Weak
hypertensionOpen Targets
0.17Weak
response to xenobiotic stimulusOpen Targets
0.16Weak
Abnormality of the skeletal systemOpen Targets
0.08Suggestive
diabetes mellitusOpen Targets
0.08Suggestive
type 2 diabetes mellitusOpen Targets
0.08Suggestive
hemolysisOpen Targets
0.05Suggestive
male reproductive system diseaseOpen Targets
0.04Suggestive
Alymphoid cystic thymic dysgenesisOpen Targets
0.04Suggestive
Obesity - colitis - hypothyroidism - cardiac hypertrophy - developmental delayOpen Targets
0.04Suggestive
obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndromeOpen Targets
0.04Suggestive
Combined hyperlipidemiaOpen Targets
0.04Suggestive
combined immunodeficiency with skin granulomasOpen Targets
0.04Suggestive
chylomicron retention diseaseOpen Targets
0.04Suggestive
immunodeficiency 15aOpen Targets
0.04Suggestive
X-Linked Combined Immunodeficiency DiseasesOpen Targets
0.04Suggestive
hypertriglyceridemia 2Open Targets
0.03Suggestive
22q11.2 deletion syndromeOpen Targets
0.03Suggestive
infectionOpen Targets
0.03Suggestive
Epidermodysplasia verruciformis 1UniProt
Pathogenic Variants36
NM_001127198.5(TMC6):c.280C>T (p.Arg94Ter)Pathogenic
Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 94
NM_001127198.5(TMC6):c.363_430+80delLikely pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2026
NM_001127198.5(TMC6):c.2130G>A (p.Trp710Ter)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025β†’ Residue 710
NM_001127198.5(TMC6):c.2022-1G>CLikely pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025
NM_001127198.5(TMC6):c.160C>T (p.Gln54Ter)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025β†’ Residue 54
NM_001127198.5(TMC6):c.967del (p.Leu323fs)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025β†’ Residue 323
NM_001127198.5(TMC6):c.1715+1G>ALikely pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025
NM_001127198.5(TMC6):c.744C>A (p.Tyr248Ter)Pathogenic
Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025β†’ Residue 248
NM_001127198.5(TMC6):c.1909C>T (p.Gln637Ter)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025β†’ Residue 637
NM_001127198.5(TMC6):c.1996_1999del (p.Val666fs)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025β†’ Residue 666
NM_001127198.5(TMC6):c.1423dup (p.Leu475fs)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025β†’ Residue 475
NM_001127198.5(TMC6):c.892-2A>GPathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2025
NM_001127198.5(TMC6):c.1383+1G>ALikely pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2024
NM_007267.7(TMC6):c.2023delLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2024
NM_001127198.5(TMC6):c.634-3_654delLikely pathogenic
Epidermodysplasia verruciformis, susceptibility to, 1
β˜…β˜†β˜†β˜†2024
NM_001127198.5(TMC6):c.892-2A>TPathogenic
Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2023
NM_001127198.5(TMC6):c.2266C>T (p.Gln756Ter)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2023β†’ Residue 756
NM_001127198.5(TMC6):c.1162del (p.Asp388fs)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2023β†’ Residue 388
NM_001127198.5(TMC6):c.846_855dup (p.Pro286fs)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2023β†’ Residue 286
NM_001127198.5(TMC6):c.115C>T (p.Gln39Ter)Pathogenic
Epidermodysplasia verruciformis
β˜…β˜†β˜†β˜†2023β†’ Residue 39
View on ClinVar β†—
Related Genes
EZH2Protein interaction97%HAVCR2Protein interaction79%TK1Protein interaction75%SLC30A1Protein interaction74%SYNGR2Protein interaction74%TMC8Protein interaction56%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
45%
Heart
14%
Brain
11%
Liver
10%
Ovary
3%
Gene Interaction Network
Click a node to explore
TMC6EZH2HAVCR2TK1SLC30A1SYNGR2TMC8
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q7Z403
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.02LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.84 [0.69–1.02]
RankingsWhere TMC6 stands among ~20K protein-coding genes
  • #9,537of 20,598
    Most Researched45
  • #1,658of 5,498
    Most Pathogenic Variants36
  • #9,991of 17,882
    Most Constrained (LOEUF)1.02
Genes detectedTMC6
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Epidermodysplasia verruciformis.
PMID: 24643182
Curr Probl Dermatol Β· 2014
1.00
2
The transmembrane channel-like 6 (TMC6) in primary sensory neurons involving thermal sensation via modulating M channels.
PMID: 38440182
Front Pharmacol Β· 2024
0.90
3
Genome-wide meta-analysis in Japanese populations identifies novel variants at the TMC6-TMC8 and SIX3-SIX2 loci associated with HbA
PMID: 29170429
Sci Rep Β· 2017
0.80
4
Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis.
PMID: 25854761
Nat Commun Β· 2015
0.70
5
Recent advances in cutaneous HPV infection.
PMID: 36601717
J Dermatol Β· 2023
0.60